Images show that people with Parkinson’s disease and cognitive impairment have brain network disruptions.
MRI can show disruptions in brain networks in the brains of people with Parkinson’s disease (PD) who have cognitive impairment, according to a study published in Radiology.
Researchers from Italy, Serbia, and the Netherlands performed a prospective study to compare the structural brain connectome in 54 patients with PD and mild cognitive impairment (MCI) and 116 patients with PD without MCI. Forty-one healthy controls also participated in the study. All subjects underwent deterministic diffusion-tensor tractography and a network-based statistic was used to assess structural connectivity differences among groups.
“Cognitive impairment in PD is one of the major non-motor complications of the disease, as well as one of the major concerns of patients and caregivers at the time of diagnosis,” coauthor Federica Agosta, MD, PhD, said in a release. “Study of the changes related to cognitive impairment in PD is imperative in order to be able to answer patients’ questions and finally be able to predict the future development of this condition.”
The results showed that patients with PD and MCI had global network alterations when compared with both control subjects and patients with PD without MCI. Relative to control subjects, patients with PD and MCI had a large basal ganglia and frontoparietal network with decreased fractional anisotropy (FA) in the right hemisphere and a subnetwork with increased mean diffusivity (MD) involving similar regions bilaterally, the authors wrote.[[{"type":"media","view_mode":"media_crop","fid":"54978","attributes":{"alt":"Federica Agosta, MD, PhD","class":"media-image media-image-right","id":"media_crop_9412829533567","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"6881","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"float: right;","title":"Federica Agosta, MD, PhD","typeof":"foaf:Image"}}]]
Subjects with PD but not MCI had decreased FA, including basal ganglia and frontotemporoparietal regions bilaterally, compared with those with MCI. Similar findings were obtained by adjusting for motor disability, patients with PD and MCI did not show network alterations relative to patients with PD without MCI. Network FA and MD values were used to differentiate patients with PD and MCI from healthy control subjects and patients with PD without MCI with fair to good accuracy.
The researchers suggested that these findings may offer markers to differentiate PD patients with and without cognitive deficits. “If confirmed and replicated by other studies, these results would suggest the use of MRI in PD to support the clinicians in monitoring the disease and predicting the occurrence of cognitive complications,” Agosta said. Further study is planned.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
Multinational Study Reaffirms Value of Adjunctive AI for Prostate MRI
June 16th 2025The use of adjunctive AI in biparametric prostate MRI exams led to 3.3 percent and 3.4 percent increases in the AUC and specificity, respectively, for clinically significant prostate cancer (csPCa) in a 360-person cohort drawn from 53 facilities.
Study: AI-Generated ADC Maps from MRI More Than Double Specificity in Prostate Cancer Detection
June 5th 2025Emerging research showed that AI-generated ADC mapping from MRI led to significant increases in accuracy, PPV and specificity in comparison to conventional ADC mapping while achieving a 93 percent sensitivity for PCa.